Examining heart changes in patients undergoing rehabilitation or bariatric surgery
Official title: Cardiovascular Imaging to Assess Responses to Metabolic Interventions
Run by The Cleveland Clinic · NCT05650307 · Data updated 2026-11-12
This study is testing how heart changes in people improve after they go through rehabilitation or weight-loss surgery to see if these changes can help spot heart problems early.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | September 9, 2022 |
| Main results expected | September 9, 2027 |
| Study ends | September 9, 2027 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT05650307 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years with symptomatic cardiovascular disease or those eligible for bariatric surgery.
✕Probably not a fit
Patients with contraindications to MRI or those from vulnerable populations, such as prisoners, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate how cardiac microstructure changes in patients before and after undergoing cardiac rehabilitation or bariatric surgery. Using cardiac MRI, the study will assess the relationship between these microstructural changes and overall cardiac function and structure. The research will involve a longitudinal cohort design, with participants undergoing MRI scans at the beginning and end of a 12-week rehabilitation program. The goal is to identify early indicators of cardiovascular disease through these imaging techniques.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of cardiovascular diseases in patients undergoing metabolic interventions.
How similar studies have gone: Other studies have shown promising results in using cardiac MRI to assess heart conditions, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years of age * Provision of written informed consent * For bariatric surgery group, obesity (BMI\>/=30 kg/m2) and non-obese (BMI \<30 kg/m2; for control group) * For cardiac rehabilitation group, symptomatic cardiovascular disease for patients and no signs of cardiovascular disease for healthy controls Exclusion Criteria: * Vulnerable populations will be excluded from this study including Prisoners * Contraindication to CMR imaging to be determined by standard MRI protocols * Decisionally impaired (e.g. dementia or cognitive disability)
Where it's running
-
Cardiovascular Innovation Research Center
Cleveland, Ohio, United States Recruiting
Study contacts
- Study coordinator: CIRC Program Coordinator
- Email: circ@ccf.org
- Phone: 216 636-5373
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure
This study tests whether offering a flu vaccine at the bedside during a hospital stay, along with counseling, increases vaccination rates for adults with acute coronary syndrome or heart failure who are at high cardiovascular risk.
-
Dapagliflozin to Improve Exercise and Heart Function in Fontan Patients
This study tests whether the diabetes drug dapagliflozin can improve exercise capacity and heart function in people who had a Fontan procedure.
-
Vicadrostat versus spironolactone: effects on kidney function and protein markers
This will test whether vicadrostat or spironolactone, each given with empagliflozin, changes kidney function and blood/urine protein patterns in adults with CKD and heart disease or heart failure.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People
This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.